SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Advanced Enzyme reports Profit after tax of Rs 201.34 Mln, in the September 2020 quarter

12 Nov 2020 Evaluate
The Revenue for the quarter ended  September 2020 of Rs. 723.15 millions grew by 22.76 % from Rs. 589.08 millions.Handsome Net Profit growth of 80.59% reported above the corresponding previous quarter figure of Rs. 201.34 millions to Rs. 111.49 millions.Operating profit for the quarter ended September 2020 rose to 303.78 millions as compared to 166.70 millions of corresponding quarter ended September 2019.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202009 201909 % Var 202009 201909 % Var 202003 201903 % Var
Sales 723.15 589.08 22.76 1337.20 1174.21 13.88 2473.54 2220.93 11.37
Other Income 17.36 11.03 57.39 24.65 27.43 -10.13 90.01 56.10 60.45
PBIDT 303.78 166.70 82.23 542.73 372.75 45.60 857.67 579.94 47.89
Interest 0.17 2.17 -92.17 0.60 4.98 -87.95 11.00 22.27 -50.61
PBDT 303.61 164.53 84.53 542.13 367.77 47.41 846.67 557.67 51.82
Depreciation 21.55 21.93 -1.73 42.73 43.24 -1.18 88.14 85.63 2.93
PBT 282.06 142.60 97.80 499.40 324.53 53.88 758.53 472.04 60.69
TAX 80.72 31.11 159.47 144.85 80.30 80.39 178.98 119.70 49.52
Deferred Tax -0.38 -6.01 -93.68 2.66 -4.60 -157.83 -14.91 0.06 -24950.00
PAT 201.34 111.49 80.59 354.55 244.23 45.17 579.55 352.34 64.49
Equity 223.36 223.35 0.00 223.36 223.35 0.00 223.36 223.30 0.03
PBIDTM(%) 42.01 28.30 48.45 40.59 31.74 27.85 34.67 26.11 32.79

Advanced Enzyme Tech Share Price

329.70 5.30 (1.63%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: